Oral delivery of xenoantigen combined with non-depleting anti-CD4 monoclonal antibody induced significant prolonged survival of concordant skin xenografts.
Niimi
M
M
First Department of Surgery, Teikyo University, Tokyo, Japan. mniimi@med.teikyo-u.ac.jp
Shirasugi
N
N
Hamano
K
K
Esato
K
K
Matsumoto
K
K
Ikeda
Y
Y
Shatari
T
T
Takami
H
H
Kodaira
S
S
D000284:Administration, Oral; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015478:Antigens, Heterophile / Q000627:therapeutic use*; D015704:CD4 Antigens / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology*; D007165:Immunosuppression Therapy / Q000379:methods*; D051379:Mice; D008808:Mice, Inbred CBA; D051381:Rats; D017207:Rats, Sprague-Dawley; D016038:Skin Transplantation / Q000276:immunology*; D013997:Time Factors; D014183:Transplantation, Heterologous / Q000276:immunology*
D000911:Antibodies, Monoclonal; D015478:Antigens, Heterophile; D015704:CD4 Antigens